Thought IVX needs a positive thread and an update, so we are looking at Human trials this year. Could be worth dollar cost averaging at these prices.
About Photodynamic Therapy (PDT)Invion is developing PhotosoftTM technology as a novel next generation Photodynamic Therapy (PDT). PDT uses non-toxic photosensitisers and light to selectively kill cancer cells and promote an anti-cancer immune response. Less invasive than surgery and with minimal side effects, PDT offers an alternative treatment option aimed at achieving complete tumour regression and long-lasting remission. . R&D activities during the quarter Invion is focused on the development of the Photosoft™ technology for the treatment of cancers and infectious diseases and atherosclerosis (AID). During the quarter, the Company continued to work with its research partners to lay the groundwork for clinical trials in at least two types of cancers – skin and anogenital. These trials are expected to commence before the end of this calendar year.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)